Misleading Presentation: Chest Pain Masking Euglycemic Diabetic Ketoacidosis Possibly Induced by Empagliflozin

Cureus. 2023 Nov 25;15(11):e49402. doi: 10.7759/cureus.49402. eCollection 2023 Nov.

Abstract

Diabetic ketoacidosis (DKA) is a life-threatening metabolic emergency traditionally associated with Type 1 diabetes but is increasingly recognized in Type 2 diabetes, particularly with the use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors. Euglycemic DKA, characterized by near-normal blood glucose levels, is a distinct variant that has gained attention. This case report highlights a unique presentation of euglycemic DKA in a 56-year-old female with a past medical history of Type 2 Diabetes Mellitus who presented to the emergency department with a one-week history of chest pain.

Keywords: atypical chest pain; diabetic ketoacidosis (dka); dka; non-st segment elevation myocardial infarction (nstemi); precipitating factors for euglycemic dka; sglt-2 inhibitor.

Publication types

  • Case Reports